Stay updated on Cediranib+Olaparib vs Other Treatments in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Cediranib+Olaparib vs Other Treatments in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cediranib+Olaparib vs Other Treatments in Ovarian Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for the pembrolizumab, cisplatin, and radiation study, including its design, eligibility criteria, outcomes, and results.
    Difference
    62%
    Check dated 2026-11-07T15:28:44.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies the site as revision v3.8.0 instead of v3.7.2, while the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T15:54:38.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error instead of study details, alongside a general NIH announcement about its terminology transition.
    Difference
    2%
    Check dated 2026-10-24T18:59:57.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T19:00:17.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T19:40:50.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the expected study details content with an access-denied message.
    Difference
    0.5%
    Check dated 2026-09-26T20:12:56.000Z thumbnail image

Stay in the know with updates to Cediranib+Olaparib vs Other Treatments in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cediranib+Olaparib vs Other Treatments in Ovarian Cancer Clinical Trial page.